Serum osteocalcin concentration in children with craniosynostosis
- Authors: Shcherbakov A.V.1, Stashko Y.F.1, Kim S.A.1, Danilin V.E.1, Letyagin G.V.1, Amelina E.V.1
-
Affiliations:
- Federal Center of Neurosurgery
- Issue: Vol 28, No 2 (2024)
- Pages: 143-150
- Section: ORIGINAL STUDY
- Submitted: 21.06.2023
- Accepted: 22.03.2024
- Published: 30.05.2024
- URL: https://jps-nmp.ru/jour/article/view/691
- DOI: https://doi.org/10.17816/ps691
- ID: 691
Cite item
Abstract
BACKGROUND: The present study is an actual one because up to now there are no standards for craniosynostosis diagnostics and no simple and safe techniques for it. Osteocalcin concentration in the blood serum is an important marker of bone metabolism, that is why this parameter was chosen as a potential laboratory marker of craniosynostosis.
AIM: To determine osteocalcin concentrations in the blood serum of children with various forms of craniosynostosis.
METHODS: 94 children with craniosynostosis who were treated in the pediatric neurosurgical department of the Federal Center for Neurosurgery of the Ministry of Health of the Russian Federation (Novosibirsk, Russia) from November 2018 to March 2022 were included in the trail. Inclusion criteria were: age up to 6 complete years, children with syndromic and non-syndromic forms of craniosynostosis. The obtained findings were analyzed in two age groups: up to 6 months and over 6 months because of different reference values.
RESULTS: 8 children out of 60, aged 6 months-6 years, had the increased osteocalcin concentration in the serum (13.3%).
CONCLUSION: No correlation has been revealed between craniosynostosis and increased serum osteocalcin concentrations in children under 6 years of age.
Keywords
Full Text
About the authors
Alexander V. Shcherbakov
Federal Center of Neurosurgery
Author for correspondence.
Email: sherba1984@mail.ru
ORCID iD: 0000-0001-6057-4805
SPIN-code: 5176-3229
MD
Россия, 132/1 Nemirovich-Danchenko street, 630087 NovosibirskYulia F. Stashko
Federal Center of Neurosurgery
Email: j_stashko@neuronsk.ru
ORCID iD: 0009-0008-1342-9232
MD
Россия, 132/1 Nemirovich-Danchenko street, 630087 NovosibirskSergey A. Kim
Federal Center of Neurosurgery
Email: s_kim@neuronsk.ru
ORCID iD: 0000-0002-9957-8122
SPIN-code: 4794-3568
MD
Россия, 132/1 Nemirovich-Danchenko street, 630087 NovosibirskVasily E. Danilin
Federal Center of Neurosurgery
Email: v_danilin@neuronsk.ru
ORCID iD: 0000-0002-7115-0159
SPIN-code: 9336-4966
MD
Россия, 132/1 Nemirovich-Danchenko street, 630087 NovosibirskGerman V. Letyagin
Federal Center of Neurosurgery
Email: g_letyagin@neuronsk.ru
ORCID iD: 0000-0001-5564-6130
SPIN-code: 6437-0871
MD, Cand. Sci. (Medicine)
Россия, 132/1 Nemirovich-Danchenko street, 630087 NovosibirskEvgenia V. Amelina
Federal Center of Neurosurgery
Email: amelina.evgenia@gmail.com
ORCID iD: 0000-0001-7537-3846
SPIN-code: 8814-0913
MD, Cand. Sci. (Physics and Mathematics)
Россия, 132/1 Nemirovich-Danchenko street, 630087 NovosibirskReferences
- Boulet SL, Rasmussen SA, Honein MA. A population-based study of craniosynostosis in metropolitan Atlanta, 1989−2003. Am J Med Genet. 2008;146(8):984–991. doi: 10.1002/ajmg.a.32208
- Panchal J, Amirsheybani H, Gurwitch R, et al. Neurodevelopment in children with single-suture craniosynostosis and plagiocephaly without synostosis. Plast Reconstr Surg. 2001;108(6):1492−1498; discussion 1499-1500. doi: 10.1097/00006534-200111000-00007
- Magge SN, Westerveld M, Pruzinsky T, Persing JA. Long-term neuropsychological effects of sagittal craniosynostosis on child development. J Craniofac Surg. 2002;13(1):99−104. doi: 10.1097/00001665-200201000-00023
- Bristol RE, Lekovic G, Rekate HL. The effects of craniosynostosis on the brain with respect to intracranial pressure. Semin Pediatr Neurol. 2004;11(4):262−267. doi: 10.1016/j.spen.2004.11.001
- Rozovsky K, Udjus K, Wilson N, et al. Cranial ultrasound as a first-line imaging examination for craniosynostosis. Pediatrics. 2016;137(2):e20152230. doi: 10.1542/peds.2015-2230
- Pogliani L, Zuccotti GV, Furlanetto M, et al. Cranial ultrasound is a reliable first step imaging in children with suspected craniosynostosis. Child’s Nervous System. 2017;33(9):1545–1552. EDN: RAZTKG doi: 10.1007/s00381-017-3449-3
- Ovchinnikov SN. The role of osteocalcin in the diagnosis of craniosynostosis in children [dissertation abstract]. Moscow, 2006. 26 р. (In Russ.)
- National Reference Laboratory [Internet]. Available from: www.aruplab.com. Accessed: 15.12.2023.
- Gundberg CM, Lian JB, Gallop PM, Steinberg JJ. Urinary-carboxyglutamic acid and serum osteocalcin as bone markers: Studies in osteoporosis and Paget’s disease. J Clin Endocrinol Metab. 1983;57(6):1221–1225. doi: 10.1210/jcem-57-6-1221
- Garrel DR, Delmas PD, Malaval L, Tourniaire J. Serum bone GLA-protein: A marker of bone turnover in hyperthyroidism. J Clin Endocrinol Metab. 1986;62(5):1052–1055. doi: 10.1210/jcem-62-5-1052
- Léger J, Thizon de Gaulle I, Czernichow P. Déminéralisation osseuse et elévation des concentrations sériques d'ostéocalcine chez les jeunes enfants atteints d'hyperthyroïdie. Ann Pediatr (Paris). 1993;40(7):404-409. (In French)
- Kim HJ, Zhao H, Kitaura H, et al. Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest. 2006;116(8):2152–2160. doi: 10.1172/JCI28084
- Crofton PM, Kelnar CJ. Bone and collagen markers in paediatric practice. Int J Clin Pract. 1998;52(8):557–565.
- De Ridder CM, Delemarre-van de Waal HA. Clinical utility of markers of bone turnover in children and adolescents. Curr Opin Pediatr. 1998;10(4):441–448. doi: 10.1097/00008480-199808000-00020
- Schonau E, Rauch F. Markers of bone and collagen metabolism-problems and perspectives in paediatrics. Horm Res. 1997;48(Suppl 5):50–59. doi: 10.1159/000191329
- Akesson K. Biochemical markers of bone turnover. A review. Acct Orthop Scand. 1995;66(4):376–386. doi: 10.3109/17453679508995567
- Lee AJ, Hodges S, Eastell R. Annals of clinical biocemestry: An international journal of biochemistry in medicine. Measurement of osteocalcin. Ann Clin Biochem. 2000;37(Pt 4):432. doi: 10.1177/000456320003700402
- Kanbur NO, Derman O, Sen TA, Kinik E. Osteocalcin. A biochemical marker of bone turnover during puberty. Int J Adolesc Med Health. 2002;14(3):235−244. doi: 10.1515/ijamh.2002.14.3.235
- Van Coeverden SC, Netelenbos JC, de Ridder CM, et al. Bone metabolism markers and bone mass in healthy pubertal boys and girls. Clin Endocrinol (Oxf). 2002;57(1):107–116. EDN: BADUEV doi: 10.1046/j.1365-2265.2002.01573.x
- Chen CJ, Chao TY, Janckila AJ, et al. Evaluationof the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth. J Pediatr Endocrinol Metab. 2005;18(1):55–62. doi: 10.1515/jpem.2005.18.1.55
- Crofton PM, Evans N, Taylor MR, Holland CV. Serum cross laps: Pediatric reference intervals from birth to 19 years of age. Clin Chem. 2002;48(4):671–673.
- Rauch F, Georg M, Stabrey A, et al. Collagen markers deoxypyridinoline and hydroxylysine glycosides: Pediatric reference data and use for growth prediction in growth hormone-deficient children. Clin Chem. 2002;48(2):315−322.